Menu
Log in

Please pardon our appearance as we make updates to our website. We hope to bring a better website experience for our members in the near future!




DATA 2000 Waiver No Longer in Effect

27 Apr 2023 3:16 PM | Anonymous

Effective December 29, 2022, the DATA 2000 waiver is no longer required to prescribe buprenorphine for opioid use disorder. Only a DEA number is needed. The removal of the x-waiver makes it easier for prescribers to provide life-saving treatment for opioid use disorder. In this video, MACS consultants and addiction medicine experts, Drs. Sarah Kattakuzhy and Michael Fingerhood share how MACS can support healthcare practitioners and their practices in providing buprenorphine and other office-based services for substance use disorders.

https://www.marylandmacs.org/MAT--MATE-Acts/Expanding-Access-to-Buprenorphine/

PO Box 1252 Millersville, MD 21108

E-mail: Management@mdapa.org

NEW phone number: (240) 207-1873

Mailing address: 8100 Three Chopt Road, OMG Suite 226, Richmond, VA 23229

Join MdAPA Today!

 Stay up to date with MdAPA news!

 Stay up date with PA practice in Maryland!

 Stay connected!

JOIN NOW

Subscribe to our Newsletter

 Stay up to date with MdAPA news!

 Stay up date with PA practice in Maryland!

 Stay connected!


Powered by Wild Apricot Membership Software